1. Home
  2. BHVN vs WULF Comparison

BHVN vs WULF Comparison

Compare BHVN & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • WULF
  • Stock Information
  • Founded
  • BHVN 2013
  • WULF 1952
  • Country
  • BHVN United States
  • WULF United States
  • Employees
  • BHVN N/A
  • WULF N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • WULF EDP Services
  • Sector
  • BHVN Health Care
  • WULF Technology
  • Exchange
  • BHVN Nasdaq
  • WULF Nasdaq
  • Market Cap
  • BHVN 1.9B
  • WULF 1.8B
  • IPO Year
  • BHVN 2017
  • WULF 1995
  • Fundamental
  • Price
  • BHVN $14.45
  • WULF $3.74
  • Analyst Decision
  • BHVN Strong Buy
  • WULF Strong Buy
  • Analyst Count
  • BHVN 14
  • WULF 9
  • Target Price
  • BHVN $58.85
  • WULF $8.22
  • AVG Volume (30 Days)
  • BHVN 2.1M
  • WULF 44.0M
  • Earning Date
  • BHVN 08-07-2025
  • WULF 08-11-2025
  • Dividend Yield
  • BHVN N/A
  • WULF N/A
  • EPS Growth
  • BHVN N/A
  • WULF N/A
  • EPS
  • BHVN N/A
  • WULF N/A
  • Revenue
  • BHVN N/A
  • WULF $132,023,000.00
  • Revenue This Year
  • BHVN N/A
  • WULF $44.72
  • Revenue Next Year
  • BHVN $59.97
  • WULF $85.27
  • P/E Ratio
  • BHVN N/A
  • WULF N/A
  • Revenue Growth
  • BHVN N/A
  • WULF 31.85
  • 52 Week Low
  • BHVN $13.87
  • WULF $2.06
  • 52 Week High
  • BHVN $55.70
  • WULF $9.30
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 33.35
  • WULF 47.27
  • Support Level
  • BHVN $14.95
  • WULF $3.97
  • Resistance Level
  • BHVN $17.73
  • WULF $4.40
  • Average True Range (ATR)
  • BHVN 0.87
  • WULF 0.34
  • MACD
  • BHVN 0.04
  • WULF -0.07
  • Stochastic Oscillator
  • BHVN 15.03
  • WULF 22.22

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: